Cholangiocarcinoma

You have access
Sequence of CX-4945 and Cisplatin Administration Determines the Effectiveness of Drug Combination and Cellular Response in Cholangiocarcinoma Cells In Vitro
JOMNARONG LERTSUWAN, ANYAPORN SAWASDICHAI, NATHAPOL TASNAWIJITWONG, KEVIN GASTON, PADMA-SHEELA JAYARAMAN and JUTAMAAD SATAYAVIVAD

Anticancer Research December 2021, 41 (12) 6155-6167; DOI: https://doi.org/10.21873/anticanres.15435
You have access
Intracellular IL-33 Attenuates Extracellular IL-33-induced Cholangiocarcinoma Cell Proliferation and Invasion via NF-κB and GSK-3β Pathways
SUPAPORN YANGNGAM, SUYANEE THONGCHOT, KULTHIDA VAETEEWOOTTACHARN, PETI THUWAJIT, MARCELA A. HERMOSO, SEIJI OKADA and CHANITRA THUWAJIT

Anticancer Research October 2021, 41 (10) 4917-4928; DOI: https://doi.org/10.21873/anticanres.15305
You have access
Adenosine Induces Autophagy in Cholangiocarcinoma Cells
JOMNARONG LERTSUWAN, JISNUSON SVASTI and JUTAMAAD SATAYAVIVAD

Anticancer Research August 2021, 41 (8) 3769-3778; DOI: https://doi.org/10.21873/anticanres.15169
You have access
Five-(Tetradecyloxy)-2-furoic Acid Alleviates Cholangiocarcinoma Growth by Inhibition of Cell-cycle Progression and Induction of Apoptosis
PIYANARD BOONNATE, RYUSHO KARIYA, PAKSIREE SARANARUK, UBON CHA’ON, KANLAYANEE SAWANYAWISUTH, SARAWUT JITRAPAKDEE, SEIJI OKADA and KULTHIDA VAETEEWOOTTACHARN

Anticancer Research July 2021, 41 (7) 3389-3400; DOI: https://doi.org/10.21873/anticanres.15126
You have access
Expression of FOXO4 Inhibits Cholangiocarcinoma Cell Proliferation In Vitro via Induction of G₀/G₁ Arrest
KITTI INTUYOD, SASITORN CHOMWONG, PHONPILAS THONGPON, KULTHIDA VAETEEWOOTTACHARN, CHAWALIT PAIROJKUL, PORNTIP PINLAOR and SOMCHAI PINLAOR

Anticancer Research December 2020, 40 (12) 6899-6905; DOI: https://doi.org/10.21873/anticanres.14713
You have access
Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines
UNCHALEE THONSRI, WUNCHANA SEUBWAI, SAKDA WARAASAWAPATI, SOPIT WONGKHAM, THIDARAT BOONMARS, UBON CHA'ON and CHAISIRI WONGKHAM

Anticancer Research September 2020, 40 (9) 5115-5124; DOI: https://doi.org/10.21873/anticanres.14515
You have access
Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow
ALESSANDRO RIZZO, ANGELA DALIA RICCI, NASTASSJA TOBER, MARIA CONCETTA NIGRO, MIRTA MOSCA, ANDREA PALLONI, FRANCESCA ABBATI, GIORGIO FREGA, STEFANIA DE LORENZO, SIMONA TAVOLARI and GIOVANNI BRANDI

Anticancer Research June 2020, 40 (6) 3013-3030; DOI: https://doi.org/10.21873/anticanres.14282
You have access
Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis
ROSA AUTORINO, SILVIA BISIELLO, BRIGIDA PAPPALARDI, VANESSA PRIVITERA, MILLY BUWENGE, FEDERICA PICCOLO, CARLOTTA MASCIOCCHI, LUCA TAGLIAFERRI, GABRIELLA MACCHIA, CLELIA DELLE CURTI, MARCO LUPPATTELI, ANNAMARIA CERROTTA, ALESSIO GIUSEPPE MORGANTI, VINCENZO VALENTINI and GIANCARLO MATTIUCCI

Anticancer Research June 2020, 40 (6) 3417-3421; DOI: https://doi.org/10.21873/anticanres.14326
You have access
Primary Hepatic Carcinosarcoma Composed of Hepatocellular Carcinoma, Cholangiocarcinoma, Osteosarcoma and Rhabdomyosarcoma With Poor Prognosis
LI LIU, ELISE AHN, KIMBERLY STUDEMAN, KURTIS CAMPBELL and JINPING LAI

Anticancer Research April 2020, 40 (4) 2225-2229; DOI: https://doi.org/10.21873/anticanres.14184
You have access
Association Between the Functional miR-146a SNP rs2910164 and Risk of Digestive System Cancer: Updated Meta-analysis
ROBIN PARK, LAERCIO LOPES and ANWAAR SAEED

Anticancer Research March 2020, 40 (3) 1495-1502; DOI: https://doi.org/10.21873/anticanres.14094

Main menu

User menu

Search

Cholangiocarcinoma

Pages